It has been known for a long time that infection of cultured cells with poliovirus results in the overall inhibition of transcription of most host genes. We examined whether selected host genes can escape transcriptional inhibition by thiouridine marking newly synthesized host mRNAs during viral infection. Using cDNA microarrays hybridized to cDNAs made from thiolated mRNAs, a small set of host transcripts was identified and their expression verified by quantitative PCR and Northern and Western blot analyses. These transcripts were synthesized from genes that displayed enrichment for NF-B binding sites in their promoter regions, suggesting that some NF-B-regulated promoters can escape the virus-induced inhibition of transcription. In particular, two negative regulators of NF-B, IBa and A20, were upregulated during viral infection. Depletion of A20 enhanced viral RNA abundance and viral yield, arguing that cells respond to virus infection by counteracting NF-B-induced proviral effects.
Infection of cells with poliovirus results in a dramatic inhibition of transcription (12) and translation (4) of host cell mRNAs. It has been known for a long time that 80 to 90% of host mRNAs cease to be transcribed around 2 h after infection of cultured cells with poliovirus (18, 42) . To investigate the mechanism of inhibition of host transcription, Dasgupta and colleagues discovered that virus-encoded proteinases cleave several cellular transcription factors, including CREB, Oct1, and the TATA-binding protein TBP (5, 6, (36) (37) (38) (39) . Here, we investigate whether inactivation of cellular transcription factors results in the transcriptional inhibition of all cellular mRNAs or whether classes of cellular mRNAs can be transcribed during virus-induced inhibition of transcription.
The host response to poliovirus infection has been previously investigated using cDNA microarray analysis (19) . This study revealed that the abundance of 12 mRNA species increased at 3 h after infection (19) . However, this approach measured the steady-state abundance of mRNAs and, thus, could reflect altered turnover of preexisting mRNAs, synthesis of new mRNAs, or both. To distinguish between these possibilities, we employed an experimental system in which newly synthesized mRNAs can be identified at different times during viral infection. Specifically, HeLa cells that express the uracilphosphoribosyltransferase (UPRT) gene from Toxoplasma gondii were infected with poliovirus. The addition of 4-thiouracil (4sU) to uninfected and infected HeLa-UPRT cells allowed the pulse-labeling of only newly synthesized RNAs that could be captured on streptavidin beads for microarray, Northern, and quantitative PCR analysis. We discovered that several host mRNAs are preferentially synthesized during poliovirus infection. Expression of most of these mRNAs increased from the early to the late stages of infection, providing evidence that these genes escape poliovirus-induced inhibition of host transcription. Most of these expressed genes are predicted to be regulated by NF-B, arguing that the encoded products likely facilitate the host innate immune responses.
MATERIALS AND METHODS
Cell culture and viral infection. HeLa cells were maintained in Dulbecco's modified Eagle's medium (DMEM) (GIBCO, Carlsbad, CA) supplemented with 10% fetal bovine serum (Omega Scientific, Tarzana, CA), 100 U/ml penicillinstreptomycin (GIBCO), and 2 mM L-glutamine (GIBCO). For infections, Mahoney type 1 poliovirus stocks were diluted in phosphate-buffered saline supplemented with 0.1 mg/ml CaCl 2 plus 0.1 mg/ml MgCl 2 (C-PBS). Cells were washed once with C-PBS and infected at a multiplicity of infection (MOI) of 5 to 50. Following incubation for 30 min at 37°C, antibiotic-free DMEM was added. Infections were allowed to proceed up to 5.5 h at 37°C. Mock infections, treated with C-PBS alone, were carried out in parallel. To label RNA, 4-thiouracil (4sU) (Acros, Geel, Belgium) stock solutions were made at a 200 mM concentration in dimethyl sulfoxide (DMSO), stored at Ϫ20°C, and thawed only once before dilution in the cell culture medium.
RNA and protein preparation. RNA and protein was prepared from 4 ϫ 10 6 HeLa cells. RNA was purified using the TRIzol (Invitrogen, Carlsbad, CA) reagent. Poly(A) ϩ mRNA was purified from total RNA using Oligotex (Qiagen, Valencia, CA). Total RNA and polyA ϩ mRNA concentrations were determined with an ND-1000 spectrophotometer (NanoDrop). Protein lysates were prepared in RIPA buffer (1% deoxycholic acid, 1% Triton X-100, 0.1% SDS, 0.1 M Tris HCl, pH 7.4, and 0.15 M NaCl). A mini-tablet of complete protease inhibitors (Roche) was added to each 10-ml aliquot of RIPA buffer. Lysates were incubated on ice for 15 min and cleared by sedimentation at 14,000 rpm for 20 min at 4°C. Total protein concentration was determined using the standard Bradford protein assay (Bio-Rad) according to the manufacturer's instructions.
Labeling and preparation of thiouridine-containing RNA. The HeLa-UPRT cell line that stably expresses the uracilphosphoribosyltransferase (UPRT) gene from Toxoplasma gondii was used in this study (7) . This HeLa-UPRT cell line enabled the incorporation of a thio-labeled uracil into RNA. Briefly, cells were infected at an MOI of 50 with live poliovirus or virus that had been heat inactivated for 15 min at 65°C. Thiouracil (15 M) was added to the medium, and RNA was extracted at different times after infection. The protocols for RNA extraction, biotinylation, purification on streptavidin beads, and preparation for Northern and cDNA microarray analyses were described by Cleary et al. (7) . cDNA microarrays. Three independent mRNA preparations were performed for each early (0.5 to 2.5 h) and late (2.5 to 5.5 h) time point. Briefly, 200 ng of poly(A) ϩ -selected mRNA was converted to first-strand cDNA using Superscript II (Life Technologies, Carlsbad, CA) and labeled with Cy5-dUTP (Amersham Pharmacia Biotech) using the Klenow enzyme (Gibco-BRL) and random monomer. As a reference, Cy3-dUTP-labeled cDNA was prepared from a universal human reference RNA (Stratagene) that hybridizes to all spots on the microarrays. The Cy5-labeled and Cy3-labeled samples were mixed, purified using YM-30 columns (Amicon), and hybridized for 20 h at 65°C to human cDNA microarray slides (Corning UltraGAPS-coated slides, SHGI standard 48-tip). These slides were obtained from the Stanford Functional Genomics Facility and contain 40,996 cDNA elements representing 23,228 unique putative genes. Controls included the DCV2.0 (Ambion/Stratagene) mRNA mix version, which is a mix of Methanococcus jannaschii mRNA controls prepared by in vitro transcription. These controls serve as controls for the efficiency of the labeling reactions and serve in data normalization.
Microarrays were scanned and gridded using GenePix 4000A and GenePix 5.1, respectively (Axon Instruments), and filtered using tools provided by the Stanford Microarray Database (SMD). Spots included in the analysis of microarrays met the following filtering criteria: regression correlation, Ͼ0.6; channel 1 intensity/median background intensity, Ͼ2.0; channel 2 normalized (intensity/median background intensity), Ͼ2.0; channel 1 net (median), Ն250, channel 2 net (median), Ն250, using only genes with Ͼ85% good data.
A total of 20,611 elements from the early time point arrays and 21,105 elements from the late time point arrays passed the filtering criteria and were entered into Me Viewer 3.1 (TIGR) for paired t test using alpha (overall threshold P value) 0.04. From the group of significant genes, those expressed at a Ͼ2-fold difference between infected and mock cells were chosen for further investigation. The complete data sets for these microarrays are available for analysis on the Stanford Microarray Database (SMD) website (http://genome -www5.stanford.edu/).
Detection of NF-B binding sites. Genes were inspected for the presence of the NF-B consensus motif GGGRNNYYCC (C, cytosine; G, guanine; N, any nucleotide; R, purine; Y, pyrimidine) in the enhancer/promoter regions (40) . Most genes containing NF-B binding sites in the promoter regions, including those in the present report, can be found on the website of Thomas D. Gilmore, Biology Department, Boston University (http://www.nf-kb.org).
qPCR. Quantitative PCR (qPCR) was performed using the QuantiTect SYBR green PCR kit (Qiagen), using iCycler iQ external well factor solution (Bio-Rad) in the iCyler (Bio-Rad) system. Reaction conditions were as follows: 15 min at 95°C (initial activation step), at least 40 cycles of 1 min at 95°C (denaturation), 1 min at 55°C (annealing), and 1 min 72°C (extension), followed by 7 min at 72°C for final extension and melting curve analysis. Dilution series (10-fold) of RNAs were used to develop a standard curve, and unknowns were run in triplicate alongside no-reverse transcriptase and no-template controls. The amplification efficiency of each target and reference was determined from the standard curve of the threshold crossing point.P]dATP. In addition, Northern probes were generated by RT-PCR using the following primer pair sequences: IL-6, CCTGAACCTTCCAAAGATGG and ATCTGAGGTGCCC ATGCTAC; CCL2, TGCTCATAGCAGCCACCTTC and GCTGCAGATTCT TGGGTTGT; IFIT2, GAAAGAGCGAAGGTGTGCTT and GCAGGTAGG CATTGTTTGGT; A20, TTGCCACAGAGCTGGAAAC and CCACTGTTGC AGTGGCAG (12a); IBa, CCTGGTGTCACTCCTGTTGA and GAGGGCT GATCCTACCACAA; IER3, CTTCCGAGGCAACTTGAACT and ACCCAC CACCAGACTTCATC; TAF7, AGACCTGCCCTGTGTTATGG and GCCTG TGACCAGACATTCCT; OCIAD1, TGAATGAATCTGCTCCCACT and AG AGTTATCTTTGCCCTTGC.
After UV light cross-linking of the RNA to the membrane, the blots were prehybridized for 30 min at 65°C in ExpressHyb hybridization buffer (Clontech) followed by a 1-h hybridization at 65°C with 10 6 cpm of 32 P-labeled probe per ml of buffer. The blots were washed according to the ExpressHyb protocol (Clontech). The signals were quantitated using a Storm PhosphorImager (Molecular Dynamics).
ELISA quantitation of secreted and intracellular IL-6. HeLa cells were infected with poliovirus at an MOI of 50 or mock infected and then harvested after 2, 3, and 5 h of incubation. Amounts of intracellular and secreted IL-6 were determined by enzyme-linked immunosorbent assay (ELISA) as recommended by the manufacturer (eBioscience). Supernatants were diluted 5-fold in assay diluent, and light absorbance at 450 nm was measured in an EL 311SX microplate autoreader (Bio-Tek Instruments). The amount of cytokine in each sample was interpolated from duplicate standard curves performed for each assay.
Immunoblot analyses and antibodies. Antibodies recognizing the following proteins were used for immunoblot analysis: actin (Sigma), IBa (Santa Cruz Biotechnology), Myc (Santa Cruz Biotechnology), A20 (Santa Cruz Biotechnology), and poliovirus (Biodesign). Immunoblots were prepared as described previously (2) , and signals were visualized with an ECF detection kit (GE Healthcare Life Sciences). ECF images were quantitated using a Storm PhosphorImager (Molecular Dynamics).
siRNA transfections. Small interfering RNAs (siRNAs) targeting A20 or green fluorescent protein (GFP) were transfected into HeLa cells at a final concentration of 100 nM using DharmaFECT 1 (Dharmacon) for 24 h. Cells were then infected with poliovirus at an MOI of 7 or were mock infected for 5 h. This low MOI ensures that most of the cells that received the siRNAs were infected with virus. siRNAs were synthesized at the Protein and Nucleic Acid facility at Stanford and are as follows: A20 set 1 sense, AGUGUGUAUCGGUGCAUG GUU; A20 set 1 antisense, CCAUGCACCGAUACACACUUU; A20 set 2 sense, GUUGCGUGUGUCUGUUUCCUU; A20 set 2 antisense, GGAAACAGACAC ACGCAACUU. SiRNA duplexes targeting GFP were purchased from Dharmacon.
Plaque assays. Intracellular virus was collected from infected cells and plaque assays were performed as described previously (20) .
RESULTS
Establishment of a protocol for the detection of newly synthesized mRNAs in living cells. To identify cellular transcripts that can escape poliovirus-induced inhibition of transcription, a protocol was established that allows the purification of newly transcribed transcripts from virus-infected cells. Briefly, we used HeLa cells that stably express the uracil-phosphoribosyltransferase (UPRT) gene from Toxoplasma (7). These UPRT HeLa cells are able to convert 4-thio-uracil (4sU) to 4-thio-UTP, which can be used as a substrate by RNA polymerases. Modified RNA can then be extracted, biotinylated, and captured on streptavidin beads (Fig. 1A) . This system was optimized so that 4sU-containing mRNAs could be detected by Northern analysis after a 45-min pulse with 15 M 4sU (see Materials and Methods).
Identification of genes that are preferentially expressed during early and late infection of HeLa cells with poliovirus. To identify cellular mRNAs that can be newly synthesized during poliovirus infection, we compared the expression of cellular genes by cDNA microarray analysis using RNA samples from three sources: from mock-infected cells, from infected cells labeled from 0.5 to 2.5 h postinfection, or from infected cells labeled from 2.5 to 5.5 h postinfection (Fig. 1B) . Extracted RNA was biotinylated, purified on streptavidin beads, and reverse transcribed into cDNA in the presence of fluorescent dUTP-Cy5. dUTP-Cy3-containing cDNA was generated from a human universal reference RNA (Stratagene) (Fig. 1B) , which hybridizes to all spots on the human cDNA microarray, and was used for quality control. Both Cy5-and Cy3-labeled cDNAs were then hybridized to human cDNA microarrays (Fig. 1B) . Three pairs of arrays for each of these conditions were compared. Using a paired t test P value of 0.04, the number of significant signals on the arrays during early infection was 1,077. The number of significant signals on the chips during late infection was 1,838. Within the groups of significant signals, we chose to study the subsets of genes with a greater than 2-fold difference in abundance in infected compared to uninfected cells.
During early poliovirus infection, the newly synthesized mRNAs from nine genes were expressed at a more than 2-fold higher rate than mock-infected cells (Table 1) . Later in poliovirus infection, newly synthesized mRNAs from 13 genes accumulated to a more than 2-fold higher abundance than mockinfected cells (Table 1) . Two of the genes identified in the early expression set, A20 and CCL2, were also in the late expression set (Table 1) .
Curiously, IBa, IL-6, CCL2, A20, SOD2, and JUNB genes contain NF-B binding sites, consisting of the B consensus motif GGGRNNYYCC, in their promoter regions (Table 1) . In contrast, IFIT1, IFIT2, and ISG15 do not contain NF-B binding sites, but they are direct targets of beta and gamma interferon, whose genes contain NF-B binding sites. Thus, a significant number of genes that are newly transcribed during poliovirus infection are likely to be regulated by NF-B.
Analyses of cellular RNA transcripts synthesized during early and late stages of poliovirus infection. To substantiate the cDNA microarray expression pattern further, cells were infected with poliovirus and pulse-labeled with 4sU from 0.5 to 2.5 h or from 2.5 to 5 h after infection, and thiolated RNA was isolated and examined by quantitative PCR (qPCR). Figure 2A shows the qPCR data, displayed as fold increases in cDNA abundance in infected cells compared to that in mock-infected cells. As revealed by the cDNA microarray, IBa, IER3, A20, MYC, IFIT1, IFIT2, SOD2, ISG15, JUN, JUNB, IL-6, and CCL2 were transcribed at a time when the transcription of control gene TAF7, HNRPH1, or ACT was inhibited ( Fig. 2A  and B) . To examine whether identified mRNAs were expressed as full-length messages, the expression of selected genes was examined by Northern analysis. The Northern blots in Fig. 2B show that full-length IBa mRNAs increased in abundance during early and late infection compared to mockinfected cells. It is noteworthy that IER3, A20, IFIT2, IL-6, and CCL2 mRNA abundances were barely detectable in mockinfected cells but that these mRNAs increased in abundance during viral infection (Fig. 2B) . In contrast, the expression of TAF7 and ACT mRNAs greatly diminished during infection compared to their amounts in mock infection (Fig. 2B) . We chose to study further selected genes with the presence of NF-B sites in their promoter regions, because of their known regulation by interferons (Table 1 ) and because we were intrigued by the preponderance of such genes in our collection. To determine whether the enhanced expression of IBa, IER3, IL-6, and CCL2 was dependent on viral gene expression or whether engagement of virus-receptor interactions could trigger enhanced transcription of these genes, we compared effects of live and inactivated virus. Northern blot analysis was performed on total RNA isolated from cells inoculated with live or heat-killed virus after 5 h of infection. Figure 3A shows that the mRNAs tested, IBa, IER3, IL-6, and CCl2, accumulated to higher abundance in cells inoculated with live virus than in cells treated with heat-killed virus or in mock-infected cells. To examine whether cellular transcription required replicating viral RNA, the abundance of A20 mRNA was examined in virus-infected cells that had been treated with the replication inhibitor guanidine hydrochloride (GnHCl). Figure  3B shows that A20 RNA accumulated to the same enhanced abundance in infected, GnHCl-treated, and control-treated cells. These findings argue that enhanced gene expression of these cellular genes is dependent on ongoing viral mRNA translation but not on viral RNA replication.
Overall, the trend of expression of genes at early and late times after infection was similar when measured by cDNA microarray, qPCR, or Northern analyses (Fig. 2) . Numerous genes involved in innate immune responses to viral infection were identified, e.g., IBa, A20, CCL2, IL-6, IFIT1, IFIT2, SOD2, JUNB, and ISG15. Of these, only IBa abundance decreased from early to late infection, arguing that the ability of these mRNAs to be newly synthesized and accumulate during poliovirus infection was robust.
Posttranscriptional control of mRNAs that are newly synthesized during poliovirus infection. To test whether increased mRNA levels during infection correlated with increased protein abundance, we compared the abundances of IL-6, A20, and IBa proteins during early and late stages of poliovirus infection. First, we noted that the amount of intracellular IL-6 abundance was much higher in cells inoculated with live virus than with killed virus, especially during early viral infection (Fig. 4A) . After 5 h of infection, the abundance of intracellular IL-6 declined rapidly. This is likely due to inhibition of IL-6 mRNA translation, IL-6 degradation, or both. Despite the intracellular accumulation of IL-6, the extracellular amount of IL-6 did not increase. This finding is likely explained by the inhibition of the host cell secretory pathway during poliovirus infection (8, 10, 11) .
Next, we examined the intracellular protein abundances of A20 and IBa using Western blot analysis. At 2 and 5 h after infection, A20 protein abundance was significantly higher in cells that were inoculated with live virus than in those inoculated with killed virus (Fig. 4B) . Although A20 mRNA abundance increased during infection ( Fig. 2A) , the A20 protein abundance remained relatively unchanged throughout infection (Fig. 4B) . IBa, on the other hand, accumulated early, but not late, in infection. The concomitant decrease of IBa mRNA ( Fig. 2A) and protein (Fig.  4B) suggests that transcriptional downregulation of this gene late in infection could contribute to the decrease in IBa protein abundance. Together, these findings suggest that mRNAs that are specifically synthesized during infection with poliovirus experience different posttranscriptional fates in the cytoplasm.
Depletion of A20 enhances poliovirus yield. Finally, we examined the function of A20, which is a negative transcriptional regulator of NF-B and a target of NF-B, in the viral life cycle. Figures 2 and 4 show that A20 mRNA and protein were expressed at higher abundances both early and late in infected cells. First, we depleted A20 RNA from HeLa cells by siRNAmediated gene depletion. Figure 5A shows that at least 50% of A20 RNA and protein could be depleted. SiA20 RNA-treated and control siGFP RNA-treated cells were infected with poliovirus and the amount of intracellular virus was determined 5 h after infection. Figure 5B shows that depletion of A20 results in a small but significant increase in production of infectious virus. This finding argues that A20 has a negative effect on poliovirus growth. To determine whether depletion of A20 affected viral RNA abundance, we measured intracellular viral RNA in siRNA A20-and siRNA GFP-treated cells. Figure 5C shows that viral RNA was increased more than 3-fold in siA20 RNA-treated cells than in siGFP RNA-treated cells. Because depletion of A20 did not alter the overall rate of cellular translation (data not shown), we speculate that A20 displays a specific antiviral effect. Because A20 is a negative regulator of NF-B, we examined the abundances of NF-B during poliovirus infection when A20 was depleted by siA20 RNAs. The results showed that A20 depletion resulted in a slight accelerated degradation of NF-B after 4 h of infection compared to that in controltreated cells (data not shown). Thus, proteinase 3C-mediated 
DISCUSSION
Previous cDNA microarray analyses have revealed that the abundance of 18 cellular mRNAs was increased in poliovirusinfected HeLa cells (19) . However, it was not known whether these mRNAs were newly synthesized or stabilized during infection. Because most host mRNAs cease to be transcribed around 2 h after infection (18, 42) , changes in cellular mRNA abundance had been attributed to changes in mRNA stability. In this study, we have marked newly transcribed RNA with thiouridine. Thiolated mRNAs can be modified with biotin and physically isolated on streptavidin beads. cDNA microarray analysis revealed that at least 20 host genes can continue to be transcribed during the early or late stages of poliovirus infection.
NF-B promoter-containing genes that can escape poliovirus-induced transcriptional inhibition. Although only 1% of known human genes contain NF-B binding sites in their promoters (14) , six of the identified host genes that were transcribed during poliovirus infection (IBa, A20, CCL2, IL-6, SOD2, JUNB) contain such sites. Three additional transcribed genes, IFIT1, IFIT2, and ISG15, do not contain NF-B binding sites but are regulated by interferons whose genes contain NF-B binding sites.
NF-B proteins are eukaryotic transcription factors that regulate the expression of genes that modulate inflammatory responses and innate immune responses to viral infection (15, 27) . In its inactive form, NF-B is sequestered in the cytoplasm by NF-B inhibitor IBa (3, 16) . Most NF-B activators converge on the IB kinase (IKK) pathway. IKK phosphorylation of IBa targets it for ubiquitination and degradation by the proteasome (32, 35). NF-B can then enter the nucleus to activate target gene expression (25, 31, 41) . Interestingly, poliovirus (26), rhinovirus (29) , and Theiler murine encephalomyelitis (28) have been reported to induce NF-B-activated host gene expression. Evidence was provided that the NF-B complex translocates to the nucleus 2 to 3 h after poliovirus infection, with concomitant degradation of IBa (26) . However, later in infection, the p65-RelA component of the NF-B complex is cleaved by viral protease 3C (26) . Similar events occur during infection with ECHO-1 and rhinovirus infection, suggesting that regulation of NF-B response by p65-RelA cleavage is shared between some picornaviruses (13, 26) . Our studies provide additional evidence that NF-B plays a role in the expression of specific genes that escape the general inhibition of host transcription during poliovirus infection. Why can certain genes escape the transcriptional inhibition during poliovirus infection? As mentioned above, virus infection induces the proteolysis of several transcription factors by viral proteinase 3C (6, 21, 22) . Curiously, some NF-B-responsive promoters, such as the one in A20, are constitutively occupied by TATA binding protein (TBP) and associated tran- scription factors during both repressed and activated states (1). It is thought that permanent occupancy may allow a more rapid transcriptional induction in response to NF-B in the presence of cytokines such as TNF-␣ (1). It is tempting to speculate that TBP is resistant to cleavage by viral proteinase 3C when it is constitutively bound in transcriptional complexes, such as some of those that are regulated by NF-B-regulated promoters.
Role for NF-B inhibitors IBa and A20 during viral infection. While several picornaviruses have been shown to activate NF-B signaling after viral infection (13, 26) , our study shows that at least two major inhibitors of NF-B signaling, IBa and A20, were transcriptionally induced during viral infection. These findings suggest that IBa and A20 have roles in innate immune responses to poliovirus infection.
IBa retains NF-B in the cytoplasm (3, 16) , and A20 is also a powerful negative regulator of NF-B, acting as a dual ubiquitin-editing enzyme. In particular, the amino-terminal domain of A20 has a deubiquitinating activity, and its carboxy-terminal domain functions as a ubiquitin ligase that interferes with TNF-␣-induced NF-B activation (34) . A20, which is also known as TNFAIP3, was originally isolated as a TNF-inducible gene from human umbilical vein endothelial cells (9) . Studies from A20-deficient mice showed that animals die shortly after birth due to multiple and severe inflammation of many organs (23) . Subsequently, it was discovered that A20 is indispensable not only to combat inflammation caused by bacteria (17) but also to modulate immune responses to virus infection (24, 30, 33) . In particular, it has been noted that A20 blocks retinoic acid-inducible gene I (RIG-I)-and interferon-regulated factor 3 (IRF3)-mediated activation of NF-B in response to RNA virus infection (24, 30, 33) . We show here that A20 mRNA and protein continue to be abundant during poliovirus infection and limit viral production. 
